ATLASATLAS fair value
₹2,090
Below fair value · 24% discount
Range: ₹1,881–₹2,299Fair valuePrice
Aurobindo Pharma (AUROPHARMA.NSE)
Aurobindo Pharma share price today, ATLAS forecast and fair value
Healthcare · Drug Manufacturers - Specialty & Generic · National Stock Exchange of India · India
₹1,590▲ +1.16%
Prices as of Oct 26, 2026 · INR
Chance of rising in 1 month
52%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Aurobindo Pharma in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Aurobindo Pharma
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS estimates Aurobindo Pharma's fair value at about ₹2,090 per share (reasonable range: ₹1,881 to ₹2,299). At ₹1,590, the stock trades 24% below it.
It is calculated with valuation multiples of comparable companies. Confidence in the estimate is medium. It is an estimate, not a promise: if the company's results change, so does its fair value.
ATLAS's model gives Aurobindo Pharma a 52% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between ₹1,525 and ₹1,668; in 9 out of 10, between ₹1,409 and ₹1,805. Estimated annual volatility is 25%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- ₹933B
- Market cap (USD)
- $9.9B
- P/E ratio
- 24.6
- Dividend yield
- 0.51%
- 52-week high
- ₹1,740
- 52-week low
- ₹1,081
- Revenue (12 months)
- ₹349B
- Operating margin
- 15.2%
- Net margin
- 10.6%
- Beta
- 0.03
What this means
These are two different questions: fair value looks at the business (what it is worth given what it earns) and the odds look at the price over the next month. Aurobindo Pharma sits below fair value and its odds of rising over a month are close to a coin flip. An expensive stock can keep climbing and a cheap one can keep falling, which is why ATLAS shows the two readings separately.
Over the last 52 weeks AUROPHARMA.NSE has traded between ₹1,081 and ₹1,740. Today it is 8.6% below that high and 47% above its low.
On the business: net margin is 10.6%; it trades at 24.6 times earnings.
Its beta is 0.03: it tends to move less than the market.
About the company
Aurobindo Pharma Ltd. is a prominent pharmaceutical company engaged in the manufacturing and marketing of a broad range of generic pharmaceuticals and active pharmaceutical ingredients (APIs).
Want to see everything about Aurobindo Pharma?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What is Aurobindo Pharma (AUROPHARMA.NSE) fair value?
About ₹2,090 per share according to ATLAS (reasonable range: ₹1,881 to ₹2,299). With the stock at ₹1,590, it is 24% below it.
What is the chance AUROPHARMA.NSE goes up next month?
52%: close to a coin flip. In half of the simulated outcomes, AUROPHARMA.NSE ends the month between ₹1,525 and ₹1,668.
How big is Aurobindo Pharma and what is its P/E ratio?
Aurobindo Pharma's market capitalization is ₹933B. Its price-to-earnings (P/E) ratio is 24.6: you pay ₹24.6 for each ₹1.00 of yearly earnings.
Does Aurobindo Pharma pay a dividend?
Yes. AUROPHARMA.NSE's current dividend yield is 0.51% at today's price (₹1,590).
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer